# OptimizeRx Corp: Form 8-K, filed Nov 13, 2024

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2024-11-13
- Accepted by EDGAR: Nov 13, 2024, 16:10 ET
- Period: 2024-11-13
- Accession: 0001213900-24-097468
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024097468/ea0221012-8k_optimize.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390024097468/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390024097468/ea0221012-8k_optimize.htm

Filed Nov 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-097468. Last ingested by Listed: Nov 14, 2026, 19:26 ET. No prices; not investment advice.
